BioPharma Dive – AI / Data

Novo uses FDA voucher to win speedy approval of higher-dose Wegovy

Published

on

The clearance, issued 54 days after an approval submission, gives Novo another chance to claw back market share from Eli Lilly. 

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version